BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38535775)

  • 1. The Utility of Spectroscopic MRI in Stereotactic Biopsy and Radiotherapy Guidance in Newly Diagnosed Glioblastoma.
    Rejimon AC; Ramesh KK; Trivedi AG; Huang V; Schreibmann E; Weinberg BD; Kleinberg LR; Shu HG; Shim H; Olson JJ
    Tomography; 2024 Mar; 10(3):428-443. PubMed ID: 38535775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing Treatment Response of Glioblastoma to an HDAC Inhibitor Using Whole-Brain Spectroscopic MRI.
    Gurbani SS; Yoon Y; Weinberg BD; Salgado E; Press RH; Cordova JS; Ramesh KK; Liang Z; Velazquez Vega J; Voloschin A; Olson JJ; Schreibmann E; Shim H; Shu HG
    Tomography; 2019 Mar; 5(1):53-60. PubMed ID: 30854442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma.
    Xu K; Ramesh K; Huang V; Gurbani SS; Cordova JS; Schreibmann E; Weinberg BD; Sengupta S; Voloschin AD; Holdhoff M; Barker PB; Kleinberg LR; Olson JJ; Shu HG; Shim H
    Tomography; 2022 Mar; 8(2):688-700. PubMed ID: 35314634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectroscopic MRI-Based Biomarkers Predict Survival for Newly Diagnosed Glioblastoma in a Clinical Trial.
    Trivedi AG; Ramesh KK; Huang V; Mellon EA; Barker PB; Kleinberg LR; Weinberg BD; Shu HG; Shim H
    Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Dimensional magnetic resonance spectroscopic imaging at 3 Tesla for early response assessment of glioblastoma patients during external beam radiation therapy.
    Muruganandham M; Clerkin PP; Smith BJ; Anderson CM; Morris A; Capizzano AA; Magnotta V; McGuire SM; Smith MC; Bayouth JE; Buatti JM
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):181-9. PubMed ID: 24986746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Radiomics and Metabolic Tumor Volumes in Radiation Treatment of Glioblastoma Multiforme.
    Lopez CJ; Nagornaya N; Parra NA; Kwon D; Ishkanian F; Markoe AM; Maudsley A; Stoyanova R
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):586-595. PubMed ID: 28011044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applying a Radiation Therapy Volume Analysis Pipeline to Determine the Utility of Spectroscopic MRI-Guided Adaptive Radiation Therapy for Glioblastoma.
    Trivedi AG; Kim SH; Ramesh KK; Giuffrida AS; Weinberg BD; Mellon EA; Kleinberg LR; Barker PB; Han H; Shu HG; Shim H; Schreibmann E
    Tomography; 2023 May; 9(3):1052-1061. PubMed ID: 37218946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D whole-brain metabolite imaging to improve characterization of low-to-intermediate grade gliomas.
    Zhong J; Huang V; Gurbani SS; Ramesh K; Scott Cordova J; Schreibmann E; Shu HG; Olson J; Han H; Giuffrida A; Shim H; Weinberg BD
    J Neurooncol; 2021 Jun; 153(2):303-311. PubMed ID: 33983570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Accuracy of MR Spectroscopic Imaging and
    Mauler J; Lohmann P; Maudsley AA; Sheriff S; Hoevels M; Meissner AK; Hamisch C; Brunn A; Deckert M; Filss CP; Stoffels G; Dammers J; Ruge MI; Galldiks N; Mottaghy FM; Langen KJ; Shah NJ
    J Nucl Med; 2024 Jan; 65(1):16-21. PubMed ID: 37884332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major Metabolite Levels of Preoperative Proton Magnetic Resonance Sectroscopy and Intraoperative Fluorescence Intensity in Glioblastoma.
    Tian HL; Zu YL; Wang CC; Lin T; Guo ZT; Jiang B; Yin X; Guo WQ; Wang ZG
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):511-517. PubMed ID: 28877829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
    Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric MR Imaging of Diffusion and Perfusion in Contrast-enhancing and Nonenhancing Components in Patients with Glioblastoma.
    Boonzaier NR; Larkin TJ; Matys T; van der Hoorn A; Yan JL; Price SJ
    Radiology; 2017 Jul; 284(1):180-190. PubMed ID: 28240563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulating the Effect of Spectroscopic MRI as a Metric for Radiation Therapy Planning in Patients with Glioblastoma.
    Cordova JS; Kandula S; Gurbani S; Zhong J; Tejani M; Kayode O; Patel K; Prabhu R; Schreibmann E; Crocker I; Holder CA; Shim H; Shu HK
    Tomography; 2016 Dec; 2(4):366-373. PubMed ID: 28105468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-institutional pilot clinical trial of spectroscopic MRI-guided radiation dose escalation for newly diagnosed glioblastoma.
    Ramesh K; Mellon EA; Gurbani SS; Weinberg BD; Schreibmann E; Sheriff SA; Goryawala M; de le Fuente M; Eaton BR; Zhong J; Voloschin AD; Sengupta S; Dunbar EM; Holdhoff M; Barker PB; Maudsley AA; Kleinberg LR; Shim H; Shu HG
    Neurooncol Adv; 2022; 4(1):vdac006. PubMed ID: 35382436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of magnetic resonance spectroscopy in frame-less stereotactic needle biopsy of glioma.
    Wang Q; Zhang J; Li F; Chen X; Xu B
    J Clin Neurosci; 2021 Jun; 88():102-107. PubMed ID: 33992167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy.
    Ratai EM; Zhang Z; Fink J; Muzi M; Hanna L; Greco E; Richards T; Kim D; Andronesi OC; Mintz A; Kostakoglu L; Prah M; Ellingson B; Schmainda K; Sorensen G; Barboriak D; Mankoff D; Gerstner ER;
    PLoS One; 2018; 13(6):e0198548. PubMed ID: 29902200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas.
    Li FM; Nie Q; Wang RM; Chang SM; Zhao WR; Zhu Q; Liang YK; Yang P; Zhang J; Jia HW; Fang HH
    Nucl Med Biol; 2012 Apr; 39(3):437-42. PubMed ID: 22172386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.
    Deviers A; Ken S; Filleron T; Rowland B; Laruelo A; Catalaa I; Lubrano V; Celsis P; Berry I; Mogicato G; Cohen-Jonathan Moyal E; Laprie A
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):385-93. PubMed ID: 25104068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of anaplastic foci within low-grade gliomas using MR spectroscopy.
    Bradac O; Vrana J; Jiru F; Kramar F; Netuka D; Hrabal P; Horinek D; de Lacy P; Benes V
    Br J Neurosurg; 2014 Oct; 28(5):631-6. PubMed ID: 24377726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.